Endocrine Connections (Oct 2022)

The correlation of the neutrophil–lymphocyte ratio to clinical and imaging parameters in patients with thyroid eye disease

  • Xiaowen Zhang,
  • Chen Han,
  • Hongwei Wang,
  • Xinghong Sun,
  • Xin Dou,
  • Xueying He,
  • Di Wu,
  • Shanmei Shen,
  • Dalong Zhu,
  • Xinlin Zhang,
  • Yan Bi

DOI
https://doi.org/10.1530/EC-22-0260
Journal volume & issue
Vol. 11, no. 11
pp. 1 – 8

Abstract

Read online

Thyroid eye disease (TED) is the major extrathyroidal manifesta tion of Graves’ disease (GD). Treatment choice is based on clinical activity and severi ty of TED, as evaluated with clinical activity score (CAS) and magnetic resonance (MR) imagi ng. We aimed to determine the relationship between neutrophil-to-lymphocyte ratio (NLR), a readily available indicator of systemic inflammation, and clinical and MR imaging parameters in TED patients. Eighty-seven consecutive TED patients were included. The average signa l intensity ratio (SIR), average extraocular muscle (EOM) diameter, and proptosis of the study eye were extracted from MR images. A baseline NLR ≥ 2.0 was recorded in 37 (42.5%) patients and NLR < 2.0 in 50 (57.5%) patients. TED patients with NLR ≥ 2.0 were older, had a higher CAS, average SIR, average EOM diameter and proptosis, and a lower serum thyrotrop hin receptor antibody level than patients with NLR < 2.0 (all P < 0.05). All MR parameters showed significant correlation with CAS (P < 0.05). NLR correlated significantly with CAS (P = 0.001), average SIR (P = 0.004), average EOM diameter (P = 0.007), and proptosis (P = 0.007). Multiple regression revealed a significant correlation between NLR and CAS (P = 0.001), average SIR (P = 0.029), and proptosis (P = 0.037). Cox regression analysis showed that a high NLR at baseline was associated with a worse clinical outcome of TED (hazard rat io 3.7, 95% CI 1.22–11.2, P = 0.02), at a median follow-up of 25 months. In conclusion, NLR was correlated with CAS and MR imaging parameters and was associated with a worse clini cal outcome of TED at follow-up in patients with TED. Additional prospective studies are needed to validate our findings.

Keywords